Young Plasma Transfusions for Progressive Supranuclear Palsy
A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy
Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability
|4||Active, not recruiting||
Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
† Study has passed its completion date and status has not been verified in more than two years.